Today’s CSR movers
ETR 4.0 ▲ 1.5
SO 3.0 ▲ 1.0
NTAP 3.6 ▲ 0.5
PWR 4.6 ▲ 0.5
SNPS 4.6 ▲ 0.5
APA 3.1 ▲ 0.1
ITW 2.7 ▲ 0.1
CF 2.9 ▼ 0.1
VMC 3.7 ▼ 0.1
COO 3.6 ▼ 0.1
Health Care · NYSE NYSE · DVA

DaVita

$181.55 +$0.22 +0.12% CLOSE 09.11.26 AFTER HOURS $181.55
Convergence score
3.9 / 5.0 BULLISH
+0.0 vs last report
Overall valuation
Undervalued
Aggregated across multiple horizons
Consensus target (12mo)
$223.43 +23.1%
Range $165.00 — $270.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 09.11.26
UV Convergence Score
REPORT 09.11.26
3.9
/ 5.0
BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Analyst average
3.7
Multi-signal aggregate How CSR works →
Day Range
$180.96 – $183.90
52W Range
$101.00 – $247.49
Volume
767.8K
Avg Vol
826.9K
Mkt Cap
$11.65B
P/E
15.39
EPS (TTM)
$11.80
Div Yield
Beta
0.83
Today's convergence

Convergence score sits at 3.9 with overall valuation reading as undervalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Undervalued
CSR direction
BULLISH
Last close
$181.55
Sector
Health Care
Valuation
Three horizons
UPDATED 09.11.26
Short term
0–3 MO
No target
Medium term
3–12 MO
$233+28.6% Buy
Long term
12–36 MO
$308.97+70.2% Undervalued
Open valuation
Analysts
Coverage & consensus
3 PANELS
Mean target (12mo)
$223.43 +23.1%
RANGE $165.00 — $270.00
Analyst consensus
Consensus rating Buy
Blended score 3.9 / 5
Analysts tracked 21
Open analysts
Financials
Key metrics
LATEST
P/E
15.39
EPS (TTM)
$11.80
Mkt Cap
$11.65B
Div Yield
Beta
0.83
52W Range
$101.00 – $247.49
Open financials
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in
Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26
Short term
0–3 MO
Consensus target
No target available
Medium term
3–12 MO
Buy
Consensus target
$233 +28.6%
RANGE $215 – $270
$215NOW $181.55$270

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Undervalued
Consensus target
$308.97 +70.2%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 09.11.26
Analyst consensus
Rating Blended score Panels Analysts
Buy 3.9 3 21
Price targets
Coverage Low Mean Median High Upside
All panels $165.00 $223.43 $220.00 $270.00 +23.1%
Rating distribution
Coverage SB B H S SS
All panels 0 7 6 0 1
Rating trend
Period Rating Avg Analysts
Current
1 Mo Ago
2 Mo Ago
3 Mo Ago
Most recent analyst action
Date
8/7/2026
Firm
TD Cowen
Action
Upgrade
Rating
Hold ➝ Buy
Target
$220.00
Financials

Full financial snapshot.

UPDATED 09.11.26
Quote snapshot
Prev Close
$181.33
Open
$181.24
Day Low
$180.96
Day High
$183.90
Bid
$174.25
Ask
$184.00
52W Low
$101.00
52W High
$247.49
50D Avg
$205.99
200D Avg
$165.07
Volume
767.8K
Avg Vol
826.9K
10D Avg Vol
573.5K
52W Change
36.16%
S&P 52W Change
15.30%
Valuation ratios
P/E (TTM)
15.39
P/E (Fwd)
10.52
PEG (Fwd)
0.45
P/S
0.83
P/B
10.73
Book Value
$-11.96
EV/Revenue
1.87
EV/EBITDA
9.25
Mkt Cap
11.65B
Enterprise Val
26.15B
Profitability & returns
Profit Margin
6.05%
Gross Margin
32.36%
Operating Margin
16.06%
EBITDA Margin
20.17%
Return on Assets
7.51%
Return on Equity
88.48%
Growth
Revenue Growth (YoY)
5.20%
Earnings Growth (YoY)
55.80%
Earnings Growth (Q)
33.10%
Balance sheet & cash flow
Total Revenue
14.01B
EBITDA
2.83B
Total Cash
688.88M
Total Debt
13.41B
Cash / Share
$10.80
Revenue / Share
$204.69
Free Cash Flow
1.04B
Operating CF
2.19B
Debt / Equity
1241.99
Current Ratio
1.47
Quick Ratio
1.33
Dividend
Fwd Dividend
Dividend Yield
Payout Ratio
0.00%
5Y Avg Yield
Ex-Div Date
Share statistics
Shares Out
64.19M
Float
33.94M
Shares Short
4.68M
% Short of Float
14.41%
Short Ratio
4.72
% Held Insiders
46.91%
% Held Institutions
48.39%
Calendar & events
Next Earnings
2026-10-28
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-06-30
Last Split
2:1
Split Date
2013-09-09
Company
Industry
Medical Care Facilities
Employees
78,000